Advertising
Showing 1 to 15 of 20 entries
BUY
Great management and growth. He's a big fan.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Aug 24/20, Up 18%) Leader in robotic surgery. Penetration is only about 5% right now, so lots of room to grow. Expensive, but very sure growth. Can hold it forever.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Apr 17/20, Up 65%) Doctors are trained to use their system so competitors find it hard to get into the market. They are starting to reduce prices on some of their tools ahead of the coming competition. He will hold it for the foreseeable future.
biotechnology / pharmaceutical
BUY
Allan Tong’s Discover Picks I recommended this last August. As we face the reopening and eventual recovery, elective surgeries will bounce back and there will be a huge backlog to process. This backlog spells a boom for any company directly tied to surgeries. That’s short term. A longer-term tailwind for ISRG stock is the continued adoption of robotic surgery and this is where the automation stock shines bright. Robotic surgeries increased from 1.8% of all operations in 2012 to 15.1% in 2018. Read 3 Underestimated Automation Stocks for our full analysis.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Jan 02/20, Up 27%) A great long-term play on robotically assisted surgery, a leader in this area. It's an expensive growth stock, but the outlook is so strong it's worth it. There's lots of room globally for surgery to adopt this technology.
biotechnology / pharmaceutical
BUY
Fractional shares to buy instead of playing the short squeeze of GameStop, AMC, etc. They make precision surgical machines which amazes him. Promising.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Aug 19/19, Up 49%) A leader in robotic surgery. It provides a better surgical experience with more precise surgeries. The long-term story is that right now, robotic surgery accounts for 4% of surgeries right now. They have a huge head start in this domain and have great cashflow.
biotechnology / pharmaceutical
BUY

JNJ JNJ is trying to respond to the rise of robotic surgery by Intuitive Surgical, which he prefers. This take time and research for JNJ, which means Intuitive will still be ahead of JNJ.

biotechnology / pharmaceutical
BUY
Allan Tong’s Discover Picks Both Jamie Murray and Bruce Murray (unrelated) see strong long-term growth ahead for the company as more surgeons adapt robotic devices. ISRG's market share is currently only 4%, but Bruce Murray expects the company to grow 50% next year and 20% after that. However, investors have already caught onto this stock and ISRG stock has almost doubled from the March 23 bottom; it has passed its $655 price target and is flirting with $700. Read BDX, BSX, ISRG and Stryker Stock: Top 4 Medical Supply Stocks for our full analysis.
biotechnology / pharmaceutical
TOP PICK
The leader in robotic surgery. They have only a 3-5% market share, but will grow as doctors grow more comfortable with robotic surgery. The PE is high, but the growth rate will catch up. He sees 50% growth next year and 20% after. This is a high-growth stock. (Analysts’ price target is $655.19)
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick Aug 19/19, Up 15%) They lead in robotic-assisted surgery, though ISRG has only 4% market penetration. They generate tons of cash with lots of recurring revenue. As more surgeries go robotic in the next 20 years, ISRG will lead the way. Buy and put this away for 20 years.
biotechnology / pharmaceutical
TOP PICK
The maker of surgical robots. They are the leader in the sector and there is no real competition. With only 5% of surgeries being done robotically there is enormous growth ahead. Yield 0% (Analysts’ price target is $546.67)
biotechnology / pharmaceutical
TOP PICK
The leader in robotic surgery. They sold about 900 units. He thinks they will continue to grow world-wide. (Analysts’ price target is $612.34)
biotechnology / pharmaceutical
TOP PICK
It is the largest company that you have never heard of. Their business is robots for surgery. It has been under a bit of pressure from a competitor but that competitor only has 4% penetration globally. (Analysts’ price target is $572.35)
biotechnology / pharmaceutical
COMMENT

Medical robotics? He does not know TMD-T well. He plays the space through and ETF of BOTZ-Q. He prefers ISRG-Q, if you wanted an individual holding.

biotechnology / pharmaceutical
Showing 1 to 15 of 20 entries

Intuitive Surgical Inc.(ISRG-Q) Rating

Ranking : 5 out of 5

Bullish - Buy Signals / Votes : 6

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 6

Stockchase rating for Intuitive Surgical Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Intuitive Surgical Inc.(ISRG-Q) Frequently Asked Questions

What is Intuitive Surgical Inc. stock symbol?

Intuitive Surgical Inc. is a American stock, trading under the symbol ISRG-Q on the NASDAQ (ISRG). It is usually referred to as NASDAQ:ISRG or ISRG-Q

Is Intuitive Surgical Inc. a buy or a sell?

In the last year, 6 stock analysts published opinions about ISRG-Q. 6 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Intuitive Surgical Inc..

Is Intuitive Surgical Inc. a good investment or a top pick?

Intuitive Surgical Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Intuitive Surgical Inc..

Why is Intuitive Surgical Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Intuitive Surgical Inc. worth watching?

6 stock analysts on Stockchase covered Intuitive Surgical Inc. In the last year. It is a trending stock that is worth watching.

What is Intuitive Surgical Inc. stock price?

On 2021-10-22, Intuitive Surgical Inc. (ISRG-Q) stock closed at a price of $341.52.